Back to Search Start Over

Development and Validation of a Prognostic Model for One-year Survival of Cirrhosis Patients with First-ever Spontaneous Bacterial Peritonitis.

Authors :
Wang RR
Gu HQ
Wei YY
Yang JX
Hou YX
Liu HM
Yang ZY
Wang XB
Jiang YY
Source :
Journal of clinical and translational hepatology [J Clin Transl Hepatol] 2021 Oct 28; Vol. 9 (5), pp. 647-654. Date of Electronic Publication: 2021 May 24.
Publication Year :
2021

Abstract

Background and Aims: Spontaneous bacterial peritonitis (SBP) is one of the leading causes of death in patients with liver cirrhosis. We aimed to establish a prognostic model to evaluate the 1-year survival of cirrhosis patients after the first episode of SBP.<br />Methods: A prognostic model was developed based on a retrospective derivation cohort of 309 cirrhosis patients with first-ever SBP and was validated in a separate validation cohort of 141 patients. We used Uno's concordance, calibration curve, and decision curve (DCA) analysis to evaluate the discrimination, calibration, and clinical net benefit of the model.<br />Results: A total of 59 (19.1%) patients in the derivation cohort and 42 (29.8%) patients in the validation cohort died over the course of 1 year. A prognostic model in nomogram form was developed with predictors including age [hazard ratio (HR): 1.25; 95% confidence interval (CI): 0.92-1.71], total serum bilirubin (HR: 1.66; 95% CI: 1.28-2.14), serum sodium (HR: 0.94; 95% CI: 0.90-0.98), history of hypertension (HR: 2.52; 95% CI: 1.44-4.41) and hepatic encephalopathy (HR: 2.06; 95% CI: 1.13-3.73). The nomogram had a higher concordance (0.79) compared with the model end-stage liver disease (0.67) or Child-Turcotte-Pugh (0.71) score. The nomogram also showed acceptable calibration (calibration slope, 1.12; Bier score, 0.15±0.21) and optimal clinical net benefit in the validation cohort.<br />Conclusions: This prediction model developed based on characteristics of first-ever SBP patients may benefit the prediction of patients' 1-year survival.<br />Competing Interests: The authors have no conflict of interests related to this publication.<br /> (© 2021 Authors.)

Details

Language :
English
ISSN :
2225-0719
Volume :
9
Issue :
5
Database :
MEDLINE
Journal :
Journal of clinical and translational hepatology
Publication Type :
Academic Journal
Accession number :
34722179
Full Text :
https://doi.org/10.14218/JCTH.2021.00031